📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Bio-Convert

1.1 - Company Overview

Bio-Convert Logo

Bio-Convert

Headquarter: Denmark
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical research and development focused on discovering and developing effective treatments for oral leukoplakia.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Bio-Convert

Ultivue Logo

Ultivue

HQ: United States Website
  • Description: Provider of tissue imaging and multiplex biomarker assay solutions for precision medicine research, including InSituPlex DNA-barcoded antibody technology, custom assay development, pre-optimized ready-to-use multiplex staining kits, specialized AI tools and full lifecycle image analysis for multiplex immunofluorescence, and OmniVUE customizable biomarker panel design kits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ultivue company profile →
Umoja Biopharma Logo

Umoja Biopharma

HQ: United States Website
  • Description: Provider of next-generation immunotherapies intended to combat cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Umoja Biopharma company profile →
Biodesix Logo

Biodesix

HQ: United States Website
  • Description: Provider of data-driven lung cancer diagnostic testing and biopharma services, offering the IQLung Treatment Guidance strategy—GeneStrat targeted, GeneStrat NGS genomic, and VeriStrat proteomic tests—to inform NSCLC treatment decisions, plus Nodify Lung testing (Nodify CDT and Nodify XL2) to assess malignancy risk in lung nodules and support early detection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biodesix company profile →
Sapience Therapeutics Logo

Sapience Therapeutics

HQ: United States Website
  • Description: Provider of novel peptide therapeutics addressing major unmet medical needs, including ST101, a peptide antagonist targeting C/EBPβ in Phase 2 for advanced solid tumors such as recurrent GBM, and ST316, a first-in-class peptide antagonist of β-catenin entering Phase 1-2 for solid tumors with Wnt/β-catenin pathway abnormalities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sapience Therapeutics company profile →
Cell Pathways Logo

Cell Pathways

HQ: United States Website
  • Description: Provider of small molecule-based drugs for cancer treatment leveraging an apoptosis technology platform, which can be used with other chemotherapy drugs, and of kits and methods for detection and quantification, including PCR ED ELISA kits for DIG-labeled PCR products, Endothelin-1 ELISA kits for multiple species, and combined PCR-ELISA nucleic acid detection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cell Pathways company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Bio-Convert

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Bio-Convert

2.2 - Growth funds investing in similar companies to Bio-Convert

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Bio-Convert

4.2 - Public trading comparable groups for Bio-Convert

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Bio-Convert

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Bio-Convert

What does Bio-Convert do?

Bio-Convert is a provider of clinical-stage biopharmaceutical research and development focused on discovering and developing effective treatments for oral leukoplakia.

Who are Bio-Convert's competitors?

Bio-Convert's competitors and similar companies include Ultivue, Umoja Biopharma, Biodesix, Sapience Therapeutics, and Cell Pathways.

Where is Bio-Convert headquartered?

Bio-Convert is headquartered in Denmark.

How many employees does Bio-Convert have?

Bio-Convert has 1,000 employees 🔒.

When was Bio-Convert founded?

Bio-Convert was founded in 2010 🔒.

What sector and industry vertical is Bio-Convert in?

Bio-Convert is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Bio-Convert

Who are the top strategic acquirers in Bio-Convert's sector and industry

Top strategic M&A buyers and acquirers in Bio-Convert's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Bio-Convert?

Top strategic M&A buyers groups and sectors for Bio-Convert include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Bio-Convert's sector and industry vertical

Which are the top PE firms investing in Bio-Convert's sector and industry vertical?

Top PE firms investing in Bio-Convert's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Bio-Convert's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Bio-Convert's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Bio-Convert's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Bio-Convert include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Bio-Convert's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Bio-Convert?

The key public trading comparables and valuation benchmarks for Bio-Convert include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Bio-Convert for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Bio-Convert with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Bio-Convert's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Bio-Convert with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Bio-Convert's' sector and industry vertical?

Access recent funding rounds and capital raises in Bio-Convert's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Bio-Convert